Abstract:Vaccination with naked DNA holds great promise but immunogenicity needs to be improved. DNA constructs encoding bivalent proteins that bind antigen-presenting cells (APC) for delivery of antigen have been shown to enhance T and B cell responses and protection in tumour challenge experiments. However, the mechanism for the increased potency remains to be determined. Here we have constructed DNA vaccines that express the fluorescent protein mCherry, a strategy which allowed tracking of vaccine proteins. Transfec… Show more
“…Further complicating the issues discussed above, the DNA vaccines of the current experiments were delivered i.m., and the types of targetable APC in skeletal muscle may be restricted compared with the body as a whole (41). Moreover, electroporation could influence APC composition due to its inflammatory effect (42,43). Finally, vaccine proteins could drain as soluble molecules to lymph nodes, and target residential APC.…”
Upon APC-targeted DNA vaccination, transfected cells secrete fusion proteins with targeting units specific for surface molecules on APC. In this study, we have tested several different targeting units for their ability to influence the magnitude and subclass of Ab responses to hemagglutinin from influenza A virus. The experiments employed bivalent homodimeric Ig-based molecules (vaccibodies). The overall efficiency in BALB/c mice depended on the targeting units in the following order: αMHC class II > αCD11c > αCD40 > Xcl-1 = MIP-1α > FliC > GM-CSF > Flt-3L > αDEC205. GM-CSF induced mainly IgG1, whereas Xcl1, MIP-1α, αCD40, and αDEC205 induced predominantly IgG2a. A more balanced mixture of IgG1 and IgG2a was observed with αCD11c, αMHC class II, Flt-3L, and FliC. Similar results of IgG subclass–skewing were obtained in Th1-prone C57BL/6 mice with a more limited panel of vaccines. IgG1 responses in BALB/c occurred early after immunization but declined relatively rapidly over time. IgG2a responses appeared later but lasted longer (>252 d) than IgG1 responses. The most efficient targeting units elicited short- and long-term protection against PR8 influenza (H1N1) virus in BALB/c mice. The results suggest that targeting of Xcr1+ conventional type 1 dendritic cells preferentially induces IgG2a responses, whereas simultaneous targeting of several dendritic cell subtypes also induces IgG1 responses. The induction of distinct subclass profiles by different surface molecules supports the APC–B cell synapse hypothesis. The results may contribute to generation of more potent DNA vaccines that elicit high levels of Abs with desired biologic effector functions.
“…Further complicating the issues discussed above, the DNA vaccines of the current experiments were delivered i.m., and the types of targetable APC in skeletal muscle may be restricted compared with the body as a whole (41). Moreover, electroporation could influence APC composition due to its inflammatory effect (42,43). Finally, vaccine proteins could drain as soluble molecules to lymph nodes, and target residential APC.…”
Upon APC-targeted DNA vaccination, transfected cells secrete fusion proteins with targeting units specific for surface molecules on APC. In this study, we have tested several different targeting units for their ability to influence the magnitude and subclass of Ab responses to hemagglutinin from influenza A virus. The experiments employed bivalent homodimeric Ig-based molecules (vaccibodies). The overall efficiency in BALB/c mice depended on the targeting units in the following order: αMHC class II > αCD11c > αCD40 > Xcl-1 = MIP-1α > FliC > GM-CSF > Flt-3L > αDEC205. GM-CSF induced mainly IgG1, whereas Xcl1, MIP-1α, αCD40, and αDEC205 induced predominantly IgG2a. A more balanced mixture of IgG1 and IgG2a was observed with αCD11c, αMHC class II, Flt-3L, and FliC. Similar results of IgG subclass–skewing were obtained in Th1-prone C57BL/6 mice with a more limited panel of vaccines. IgG1 responses in BALB/c occurred early after immunization but declined relatively rapidly over time. IgG2a responses appeared later but lasted longer (>252 d) than IgG1 responses. The most efficient targeting units elicited short- and long-term protection against PR8 influenza (H1N1) virus in BALB/c mice. The results suggest that targeting of Xcr1+ conventional type 1 dendritic cells preferentially induces IgG2a responses, whereas simultaneous targeting of several dendritic cell subtypes also induces IgG1 responses. The induction of distinct subclass profiles by different surface molecules supports the APC–B cell synapse hypothesis. The results may contribute to generation of more potent DNA vaccines that elicit high levels of Abs with desired biologic effector functions.
“…Electroporation increases the number of transfected cells and hence the levels of secreted APC-targeted vaccine proteins. Additionally, local inflammation induced by electroporation may contribute to enhanced immune responses (44,45). In this study, we have compared DNA delivery by i.d.…”
It has been difficult to translate promising results from DNA vaccination in mice to larger animals and humans. Previously, DNA vaccines encoding proteins that target Ag to MHC class II (MHC-II) molecules on APCs have been shown to induce rapid, enhanced, and long-lasting Ag-specific Ab titers in mice. In this study, we describe two novel DNA vaccines that as proteins target HLA class II (HLA-II) molecules. These vaccine proteins cross-react with MHC-II molecules in several species of larger mammals. When tested in ferrets and pigs, a single DNA delivery with low doses of the HLA-II–targeted vaccines resulted in rapid and increased Ab responses. Importantly, painless intradermal jet delivery of DNA was as effective as delivery by needle injection followed by electroporation. As an indication that the vaccines could also be useful for human application, HLA-II–targeted vaccine proteins were found to increase human CD4+ T cell responses by a factor of ×103 in vitro. Thus, targeting of Ag to MHC-II molecules may represent an attractive strategy for increasing efficacy of DNA vaccines in larger animals and humans.
“…mostraram que esse influxo de células está particularmente relacionado à administração de pulsos elétricos e não ao DNA plamidial, visto que animais que receberam apenas a EP apresentaram resultados semelhantes aos que receberam a EP associada à inoculação com DNA. Outros estudos demonstraram que a EP, além de aumentar a eficiência de transfecção, também é capaz de promover uma inflamação local, induzindo a produção de citocinas inflamatórias e o recrutamento de células do sistema imune como monócitos, macrófagos (LEBLANC et al, 2008;LUXEMBOURG et al, 2006;), células dendríticas, células natural killer, (AIHARA et al, 1998;BEST et al, 2009;LØVÅS et al, 2014;MIR et al, 1999), células B e T infiltradas (LIU et al, 2008), tornando o ambiente mais propício para a apresentação de antígenos e o desencadeamento da uma resposta imune efetiva.…”
SALES, N. S. Effects of the in vivo electroporation in the induced immune response by DNA vaccines against induced tumors by HPV-16. 2015. 63 p. Masters thesis (Microbiology) -Instituto de Ciências Biomédicas, Universidade de São Paulo, São Paulo, 2015.Cervical cancer is the third leading cause of cancer death among women in the world and the fourth cause of cancer death in women in Brazil. It's main etiological agent is human papilloma virus (HPV). More than 100 types of this virus have been identified and about 40 of them infect anogenital mucosal tissues. Among them, they are classified as high or low risk viruses according to their oncogenic potential. Among the high-risk virus types, HPV-16 and HPV-18 are considered the main cause of cervical cancer, being responsible for around 85% of the cases. Efforts are being made in the search for immunotherapeutic strategies against HPV-induced tumors, since the prophylactic vaccines now commercialized, are not able to benefit already infected individuals or patients with established cancer. In this context, DNA vaccines have demonstrated good efficacy against these tumors in murine studies, and are considered safe, stable and capable of inducing specific immune response. However, these formulations have shown immunogenicity in humans, requiring the use of approaches that increase the efficacy of these vaccines, such as the use of adjuvants, codon optimization and the use of different plasmid delivery systems. The in vivo electroporation (EP) is a method for delivering DNA vaccines, consisting on the application of electric pulses that open transient pores in the cell membrane and facilitate DNA entry into the cell. This technique has been extensively studied for its ability to potentiate the effect of DNA vaccines. Our group has developed a DNA vaccine expressing the E7 protein of HPV-16 fused to glycoprotein D (gD) of herpes simplex virus type 1 (HSV-1) (pgDE7h). The use of EP for the delivery of 50 µg of the vaccine by the intramuscular route (im) increased the therapeutic effect in mice challenged with the TC-1 tumor cell line that expresses the HPV-16 E6 and E7 proteins, generating full anti-tumor protection. The vaccine combined to EP induced increased cell transfection by plasmid DNA and the migration of pro-inflammatory cells to the inoculation site. It was also observed an enhanced activation of CD8 + E7-specific cells, with greater cytotoxic ability and capacity of secreting IFN-γ, IL-2 and TNF-α simultaneously. It was also observed an increased frequency of CD8 + T cells with greater avidity and effector memory phenotype in animals subjected to the electroporation immunization system. The use of EP in immunizations through the intradermal (id) route was not able to improve the vaccine effectiveness. In conclusion, the present results consolidated the EP as a powerful technique to potentiate the therapeutic effect induced by the pgDE7h vaccine administered by intramuscular injection reinforcing its potential for use in future clinical trials.
APC -Antigen pr...
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.